Big Chains Put a Lock on First-Run Movies

Related Link: 

Multiplex movie chains are more frequently gaining exclusivity of new releases in certain areas, shutting out independent theaters.

Globalfoundries to Take Over IBM Chip Unit

Related Link: 

IBM will pay Globalfoundries $1.5 billion to take over IBM’s semiconductor operations.

Apple Pay Rolls Out, With Holes

Related Link: 

Apple Inc. on Monday will begin its bold undertaking to add a wallet to its iPhones. Participants include McDonald’s, Whole Foods and Walgreen. Yet the service won’t be ubiquitous overnight.

Bids Target Transfield, Tenix

Related Link: 

Two Australian engineering firms with the same founder—an Italian immigrant who came to construct power cables in Sydney in the early 1950s—coincidentally became the subject of multimillion-dollar takeover bids on the same day.

Electrolux Wrings Out Improved Profit

Related Link: 

Electrolux said profit jumped 42% in the latest quarter, boosted by strong operational recovery in Europe despite a continued tough market situation.

Australia Sets Medibank IPO

Related Link: 

Australia’s government said it aims to raise as much as $4.82 billion through an initial public offering of the country’s biggest health insurer.

Shire's Interim Finance Chief Quits

Related Link: 

Shire has announced that James Bowling, the Dublin-based drug developer’s interim chief financial officer, is stepping down only days after the board of AbbVie walked away from a $54 billion planned takeover of the company.

Group Seeks Adidas's Reebok Unit

Related Link: 

An investor group from Hong Kong and Abu Dhabi is launching a bid to buy Reebok from Adidas in a move that would unwind a disappointing eight-year marriage of sneaker makers.

Metro Hurt by Strong Euro

Related Link: 

Metro reported a 2.6% decline in fourth-quarter sales after a strong euro and asset disposals derailed growth, though the German retailer said it would meet targets for the year.

Philips Swings to Loss

Related Link: 

Philips said it swung to a net loss for the third quarter because of a production suspension at one of its health-care plants and a €366 million legal provision.

Syndicate content